Answers are grounded in this paper and cite their sources.
Therapeutic drug monitoring ensures safe and effective pharmacotherapy by maintaining drug concentrations within a therapeutic range. However, conventional liquid chromatography-mass spectrometry workflows are restricted to clinical laboratories and limited by complicated sample preparation and long analysis times. Here we describe an on-site therapeutic drug monitoring protocol by integrating paper-capillary spray ionization with a miniature linear ion trap mass spectrometer. It consumes several microliters of biofluid without sample preparation and can provide results in 2 min. The protocol was validated by analyzing linezolid, carbamazepine, imatinib, and lamotrigine in blood samples, showing low limits detection as low as 50 ng/mL, RSD below 15%, and good linearity (R² > 0.99) across five orders of magnitude. The protocol is promising in fast and on-site monitoring of a wide range of therapeutic drugs in biofluids.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: